Corimmun
Key Facts
Invested since | 2006 |
Based in | Bavaria |
About the company

Corimmun is a drug-developing biotech company which focuses on personalized medicine in cardiovascular diseases. We concentrate on innovative peptide and biological drugs in indications with unmet medical needs.
Exit since June 2012.